Wuhan Keqian Biology Co Ltd (688526) — Cash Flow Quality Index
Wuhan Keqian Biology Co Ltd (688526) has a Cash Flow Quality Index of 1.48x as of September 2025. Operating cash flow of CN¥174.36 Million exceeds net income of CN¥117.90 Million, indicating high earnings quality where cash backs reported profits. Explore 688526 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Wuhan Keqian Biology Co Ltd Cash Flow Quality Index (2016–2024)
Historical Cash Flow Quality Index for Wuhan Keqian Biology Co Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 688526 cash flow metrics.
Annual Cash Flow Quality Index for Wuhan Keqian Biology Co Ltd (2016–2024)
Year-by-year earnings quality comparison for Wuhan Keqian Biology Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.03x | CN¥392.68 Million | CN¥381.49 Million | ▼ -24.3% |
| 2023 | 1.36x | CN¥538.03 Million | CN¥395.93 Million | ▲ +31.2% |
| 2022 | 1.04x | CN¥423.71 Million | CN¥409.15 Million | ▲ +11.2% |
| 2021 | 0.93x | CN¥531.27 Million | CN¥570.64 Million | ▲ +4.2% |
| 2020 | 0.89x | CN¥400.14 Million | CN¥447.80 Million | ▲ +40.0% |
| 2019 | 0.64x | CN¥154.89 Million | CN¥242.64 Million | ▼ -29.4% |
| 2018 | 0.90x | CN¥351.83 Million | CN¥388.91 Million | ▼ -14.2% |
| 2017 | 1.05x | CN¥337.61 Million | CN¥320.31 Million | ▼ -11.1% |
| 2016 | 1.19x | CN¥220.69 Million | CN¥186.17 Million | — |